Inhibition of the SerpinB3/protease-activated receptor 2 axis reduces liver cancer development and affects lipid metabolism. (PubMed, Br J Cancer) - Apr 24, 2026 - "1-PPA administration prevents lipid accumulation and HCC development in MASH-related liver carcinogenesis."
Journal • Fibrosis • Hepatocellular Cancer • Hepatology • Immunology • Liver Cancer • Metabolic Disorders • Metabolic Dysfunction-Associated Steatohepatitis • Metabolic Dysfunction-Associated Steatotic Liver Disease • Oncology • Solid Tumor • SERPINB3
|
|
Alessandra Biasiolo; Alessandro Gambella; Andrea Martini; Arantza Sanz-Parra; Barbara Oliviero; Claudia Gil-Pitarch; Claudia M Rejano-Gordillo; Cristian Turato; Gianmarco Villano; Irene González-Recio; Jessica Nurcis; Jon Ander Barrenechea-Barrenechea; L Estefanía Zapata-Pavas; Maria Guido; María Luz Martinez-Chantar; Mariagrazia Ruvoletto; Maurizio Parola; Naroa Goikoetxea-Usandizaga; Patricia Peña-Sanfélix; Patrizia Pontisso; Pietro Guerra; Santina Quarta; Silvia Cagnin; Silvia De Siervi; Stefania Cannito; Stefania Mantovani
|